Weight Loss Drug Will Be Offered for $499 a Month for Some Patients
Some commercially insured patients stand to save $150 per month on Wegovy, a popular obesity medication. Patients on Medicare and Medicaid are not eligible.
Why weight-loss drugs are the top target of Medicare price negotiations
Everyone is talking about or using weight loss products. So, the government pounces. A batch of 17 drugs are on a list of medications in a second round of
Novo Nordisk slashes Wegovy prices through direct-to-consumer pharmacy
Medicare enrollees can receive coverage for ... to the FDA-approved versions of the drugs and this new program from Novo Nordisk appears to cater to individuals who were accustomed to getting ...
Wegovy price cut: Novo Nordisk cuts the price of the weight-loss drug for the uninsured
After Zepbound-maker Eli Lilly reduced the price of the weight-loss drug, competitor Novo Nordisk has cut the price of weight-loss drug Wegovy.
Novo Nordisk CEO warns tariffs could send the prices of Ozempic and Wegovy higher
Insurance companies generally cover Ozempic and Wegovy when it is prescribed for Type-2 diabetes. However, when the drugs are used for weight loss, it’s less certain. Patients m
Novo Nordisk (NVO) Warns of Drug Shortages if Tariffs Are Imposed
Novo Nordisk (NVO), the company behind popular diabetes and weight loss medications Ozempic and Wegovy, warned that President Trump’s tariffs
Novo Nordisk Drops Price of Weight-Loss Drug Wegovy for Some Patients Paying Out of Pocket
Key Takeaways Novo Nordisk is lowering the price of its weight-loss drug Wegovy to $499 per month for some patients paying out of pocket.The deal is available through the drugmaker's new NovoCare Pharmacy offering.
Novo Nordisk shares jump after Wegovy price cuts announced
Novo Nordisk announced launching a direct-to-patient online pharmacy NovoCare, offering a more than half-price cut for its weight-loss treatment Wegovy. View on euronews
STAT1h
Pharmalittle: We’re reading about HHS buyout offers, a Novo obesity trial, and more
Most HHS workers were emailed an offer to leave their job for as much as $25,000 as part of President Trump’s government cuts ...
Novo Nordisk slashes Wegovy price for patients lacking insurance benefits
Novo Nordisk said it will offer all doses of Wegovy for $499 a month to patients paying cash, a bid to reach consumers who ...
Novo Nordisk offers Wegovy for less than half the price through new direct-to-consumer pharmacy
The pharmacy, called NovoCare, will allow patients to pay $499 in cash per month for the blockbuster weight loss drug.
Medicare spending on diabetes drugs surged over 5 years, US report shows
Medicare spending on some diabetes drugs, including popular treatments such as Ozempic, surged nearly five-fold to $35.8 ...
Managed Healthcare Executive4d
Novo Nordisk Lowers Wegovy Price for Cash-Paying Patients
NovoCare Pharmacy will provide all dose strengths of Wegovy at a reduced cost of $499 per month for cash-paying patients ...
24/7 Wall St. on MSN13d
HIMS is Out. Is Novo Nordisk or Eli Lilly the Better GLP-1 Buy?
The Food & Drug Administration announced last week that the Ozempic and Wegovy shortage for Novo Nordisk‘s (NYSE:NVO) was ...
Pharmaceutical Commerce4d
Novo Nordisk Launches DTP Delivery Service for Wegovy
Novo Nordisk, the manufacturer of Weggovy, is growing its offerings by creating NovoCare Pharmacy, a direct-to-patient (DTP) ...
Yahoo Finance5d
Novo Nordisk Plunges 21% in 3 Months: Buy, Sell or Hold the Stock?
Novo Nordisk NVO shares have lost 21% in the past ... again leading to a loss of market share. Medicare has also selected NVO’s semaglutide medicines for the second round of price negotiations ...